# A Study to Compare Two Bioanalytical Assays for Tebipenem

> **NCT05856747** · PHASE1 · COMPLETED · sponsor: **Spero Therapeutics** · enrollment: 20 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** TBP-PI-HBr

## Key facts

- **NCT ID:** NCT05856747
- **Lead sponsor:** Spero Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-04
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05856747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05856747, "A Study to Compare Two Bioanalytical Assays for Tebipenem". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05856747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*